Skip to main content
. 2019 Mar 18;19:68. doi: 10.1186/s12906-019-2474-z

Table 2.

Side effects and adverse reactions

Study Sample size Side effects and adverse reactions in articles
Maoto + NAIs NAIs Maoto Maoto + NAIs NAIs Maoto
Fukutomi 2005 [18] 10 12 None None
Kubo 2007 [20] 17 18 3 discontinued maoto None
Taketani 2008 [22] 40 145 None None
Tsuji 2011 [28] 28 30 23 2 cases of diarrhoea,
2 cases of vomiting,
1 case of abdominal pain,
1 case of mental excitement
1 case of diarrhoea,
1 cases of vomiting,
2 cases of abdominal pain,
2 cases of mental excitement,
1 case of dizziness,
1 case of periorbital oedema
2 cases of diarrhoea,
1 case of vomit
Toriumi 2012 [30] 89 124 58 11 discontinued treatment,
3 developed bacterial infection,
3 developed dehydration
4 discontinued treatment,
1 changed treatment,
3 cases of abnormal behaviour,
1 developed bacterial infection,
3 developed dehydration
5 discontinued treatment,
4 changed treatment,
3 developed bacterial infection
Kawamura 2007 [19] 43 86 10 cases of abnormal behaviour 9 cases of abnormal behaviour
Kawamura 2008 [21] 47 125 N/A N/A
Kawamura 2009 [23] 33 97 N/A N/A
Mori 2010 [24] 40 19 N/A N/A
Nabeshima 2010 [25] 8 12 None None
Suzuki 2011 [27] 46 40 N/A N/A
Nabeshima 2012 [29] 22 11 1 case of mild transaminase elevation, 1 discontinued treatment 1 case of mild transaminase elevation

NAI neuraminidase inhibitor; None, no reported side effects or adverse reactions in the arm, N/A not available

Sample sizes differ from those in Additional file 2: Table S1 for studies including loss-to-follow-up-participants in the analysis of side effects